Moreover, a selected set of serum soluble mediators (IL-6, IFN-γ, IL-1Ra, IL-13, PDGF and IL-7) were pointed out as promising biomarkers for the clinical management of severe COVID-19 patients. This evidence concerns the gene IL6 and COVID-19.